The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Leukemia. 2016 Sep;30(9):1963. doi: 10.1038/leu.2016.184.
No abstract available

Publication types

  • Published Erratum